B
Bela Patel
Researcher at University of Texas Health Science Center at Houston
Publications - 67
Citations - 2182
Bela Patel is an academic researcher from University of Texas Health Science Center at Houston. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 12, co-authored 40 publications receiving 1483 citations. Previous affiliations of Bela Patel include University of Texas at Austin.
Papers
More filters
Journal ArticleDOI
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial
Donald P. Tashkin,Michael D. Roth,Philip J. Clements,Daniel E. Furst,Dinesh Khanna,Eric C. Kleerup,Jonathan G. Goldin,Edgar Arriola,Elizabeth R. Volkmann,Suzanne Kafaja,Richard M. Silver,Virginia D. Steen,Charlie Strange,Robert A. Wise,Fredrick M. Wigley,Maureen D. Mayes,David J. Riley,Sabiha Hussain,Shervin Assassi,Vivien Hsu,Bela Patel,Kristine Phillips,Fernando J. Martinez,Jeffrey A. Golden,M. Kari Connolly,John Varga,Jane Dematte,Monique Hinchcliff,Aryeh Fischer,Jeffrey J. Swigris,Richard T. Meehan,Arthur C. Theodore,Robert W. Simms,Suncica Volkov,Dean E. Schraufnagel,Mary Beth Scholand,Tracy M. Frech,Jerry A. Molitor,Kristin B. Highland,Charles A. Read,Marvin J. Fritzler,Grace Kim,Chi-Hong Tseng,Robert Elashoff +43 more
TL;DR: In this article, the authors used a modified intention-to-treat analysis using an inferential joint model combining a mixed-effects model for longitudinal outcomes and a survival model to handle non-ignorable missing data.
Journal ArticleDOI
Management of Adults with Hospital-acquired and Ventilator-associated Pneumonia.
Christopher T. Erb,Bela Patel,Jeremy E. Orr,Thomas Bice,Jeremy B. Richards,Mark L. Metersky,Kevin C. Wilson,Carey C. Thomson +7 more
Journal ArticleDOI
Association of telemedicine for remote monitoring of intensive care patients with mortality, complications, and length of stay.
TL;DR: Remote monitoring of ICU patients was not associated with an overall improvement in mortality or LOS, and there was a significant interaction between the tele-ICU intervention and severity of illness.
Journal ArticleDOI
Early Outpatient Treatment for Covid-19 with Convalescent Plasma
David Sullivan,Kelly A. Gebo,Shmuel Shoham,Evan M. Bloch,Bryan Lau,Aarthi Shenoy,Giselle Mosnaim,Thomas J. Gniadek,Yuriko Fukuta,Bela Patel,Sonya L. Heath,Adam C. Levine,Barry Meisenberg,Emily S Spivak,Shweta Anjan,Moises A. Huaman,R. E. Blair,Judith S. Currier,James H. Paxton,Jonathan M. Gerber,Joann Petrini,Patrick B Broderick,W P Rausch,Marie Elena Cordisco,Jean M Hammel,B. Greenblatt,Valerie Cluzet,Daniel L. Cruser,Kevin Oei,M. S. Abinante,Laura L. Hammitt,Catherine G. Sutcliffe,Donald N. Forthal,Martin S. Zand,Edward R. Cachay,Jay S. Raval,Seble Kassaye,E C Foster,Michael Roth,Christi E. Marshall,Anusha Yarava,Karen Lane,Nichol McBee,Amy L. Gawad,Nicky Karlen,Atika Singh,Daniel E. Ford,Douglas A. Jabs,Lawrence J. Appel,David M. Shade,Stephan Ehrhardt,Sheriza N. Baksh,Oliver Laeyendecker,Andrew Pekosz,Sabra L. Klein,Arturo Casadevall,Aaron A.R. Tobian,Daniel F. Hanley +57 more
TL;DR: In participants with Covid-19, most of whom were unvaccinated, the administration of convalescent plasma within 9 days after the onset of symptoms reduced the risk of disease progression leading to hospitalization.
Journal ArticleDOI
Combination therapy with oral treprostinil for pulmonary arterial hypertension: A double-blind placebo-controlled clinical trial
R. James White,Carlos Jerjes-Sánchez,Gisela Martina Bohns Meyer,Tomas Pulido,Pablo Sepúlveda,Kuo Yang Wang,Ekkehard Grünig,Shirish Hiremath,Zaixin Yu,Gangcheng Zhang,Wei Luen James Yip,Shuyang Zhang,Akram Khan,C. Q. Deng,Rob Grover,Victor F. Tapson,Graciela Svetliza,Adrian Jose Lescano,Guillermo Roberto Bortman,Fabian Antonio Diez,Christian Edgardo Botta,John E. Fitzgerald,Eelke Feenstra,Fiona Kermeen,Anne Keogh,Trevor Williams,Peter Paul Yousseff,Benjamin Joh Han Ng,David Smallwood,Nathan Dwyer,Martin Brown,Irene M. Lang,Regina Steringer-Mascherbauer,Jaquelina Sonoe Ota Arakaki,Frederico Campos,Ricardo de Amorim Corrêa,Rogério Souza,Maria Auxiliadora do Carmo Moreira,Hugo Hyung Bok Yoo,Monica Silveira Lapa,John R. Swiston,Naushad Hirani,Sanjay Mehta,Evangelos D. Michelakis,Monica Zagolin,Jimming Liu,Lei Pan,Bao Chun-de,Yi Qun,Xiaoshu Cheng,Xinli Li,Yao Hua,Xianyang Zhu,Yundai Chen,Zhaozhong Cheng,Yuanhua Yang,Daxin Zhou,Jieyan Shen,Jens Erik Nielsen-Kudsk,Jørn Carlsen,Arnaud Bourdin,Eric Hachulla,Claire Dromer,Ari Chaouat,Martine Reynaud-Gauber,Hans Klose,Michael Halank,Gert Höffken,Ralf Ewert,Stephan Rosenkranz,Ulrich Kruger,Juliane Kronsbein,B. Hauptmeier,Andrea Koch,Matthias Held,Tobias J. Lange,Claus Neurohr,Heinrike Wilkens,Hubert Wirtz,Stavros Konstantinides,Paraskevi Argyropoulou-Pataka,Stylianos E. Orfanos,Prafulla Gopinath Kerkar,Pujar Venkateshacharya Suresh,Hemang Baxi,Abraham Oomman,Rajpal K. Abhaichand,P. K. Edla Kumar,Vijay Chopra,Rahul Mehrotra,Rajeev Kumar Rajput,Jitendra Singh Sawhney,Subir Bimalendu,Kamal Sharma,B. K. Srinivasa Sastry,M.R. Kramer,Michael J. Segel,Issahar Ben-Dov,Neville Berkman,Mordechai Yigla,Yochai Adir,Michael D'Alto,Carmine Dario Vizza,Laura Scelsi,Patrizio Vitulo,Tomás Pulido,Anko Boonstra,Madelon Clementina Vonk,Bożena Sobkowicz,Tatiana Mularek-Kubzdela,Adam Torbicki,Piotr Podolec,Lim Soo Teik,Hyuk Jae Chang,Hyung Kwan Kim,Jun Bean Park,Sung A. Chang,Duk Kyung Kim,Wook-Jin Chung,Jong Min Song,Magnus Nissell,Clara Hjalmarsson,Bengt Rundqvist,Wei Chun Huang,Chin Chang Cheng,Chih Hsin Hsu,Hsao-Hsun Hsu,John G Coghlan,David G. Kiely,Joanna Pepke-Zaba,James Lordan,Paul A. Corris,Linda Cadaret,Sif Hansdottir,Ronald J. Oudiz,David B. Badesch,Michael A. Mathier,Robert Schilz,Nicholas S. Hill,Aaron B. Waxman,Catherine J. Markin,Diane Zwicke,Micah R. Fisher,Veronica Franco,Namita Sood,Myung H. Park,Roblee P Allen,Jeremy Feldman,Vijay Balasubramanian,Vandana Seeram,Abubakr A. Bajwa,Austin B. Thompson,Christina Migliore,Jean M. Elwing,John W. McConnell,Jinesh Mehta,Franck Rahaghi,J. Eduardo Rame,Bela Patel,Ron M. Oren,James R. Klinger,Hassan Alnuaimat,Samuel A. Allen,William Harvey,Michael S. Eggert,Antoine Hage,Chad E. Miller,Rana Awdish,Hector Cajigas,Daniel C. Grinnan,Benjamin Howard Trichon,Clark McDonough,Franz Rischard +172 more
TL;DR: Oral treprostinil–assigned participants had a substantially higher mortality risk at baseline but achieved a lower risk profile from Study Weeks 12–60, and the most common adverse events were headache, diarrhea, flushing, nausea, and vomiting.